| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.47B | +10.7% |
| Cost of Revenue | $786.0M | +12.1% |
| Gross Profit | $687.0M | +9.2% |
| R&D Expense | $189.1M | -6.1% |
| SG&A Expense | $135.8M | +3.8% |
| Operating Income | $157.5M | +103.8% |
| Pre-tax Income | $204.8M | +70.5% |
| Income Tax | $32.7M | +86.7% |
| Net Income | $172.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $474.3M | +28.5% |
| Short-term Investments | $1.04B | -17.1% |
| Accounts Receivable | $229.9M | +2.7% |
| Inventory | $288.0M | +74.6% |
| Current Assets | $2.61B | +12.0% |
| Total Assets | $3.51B | +8.0% |
| Current Liabilities | $1.26B | +91.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $136.5M | -73.4% |
| Capital Expenditures | $40.6M | +20.9% |
| Investing Cash Flow | $106.8M | -16.7% |
| Financing Cash Flow | -$241.6M | +47.5% |
| Free Cash Flow | $95.9M | -80.0% |
| +67.7% |
| EPS (Basic) | $1.31 | +72.4% |
| EPS (Diluted) | $1.29 | +72.0% |
| Long-term Debt |
| $1.20B |
| -7.5% |
| Total Liabilities | $2.42B | +0.3% |
| Stockholders' Equity | $1.09B | +30.5% |